Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Typesort descending Therapeutic or Technology Institution Stage Project Objective Details
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy Lundquist Institute
Development Candidate, Proof of Concept
Muscular Dystrophy Embryonic Stem Cell Protein/peptide therapy Juvena Therapeutics Inc
Pre-IND/IDE or Equivalent
Heart failure Embryonic Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Age-related macular degeneration Embryonic Stem Cell Biologic USC
Pre-IND/IDE or Equivalent
Type 1 diabetes Embryonic Stem Cell Donor cell therapy ViaCyte
Clinical Trial, Phase 1 or Phase 1/2
COVID-19 Embryonic Stem Cell,
iPS Cell
Gene-modified, donor cell therapy COH
Proof of Concept
Liver Disease iPS Cell Diagnostic Test UCSF
Development Candidate, Proof of Concept
Heart Disease iPS Cell Protein/peptide therapy Regencor, Inc.
Pre-IND/IDE or Equivalent
Dementia iPS Cell Donor cell therapy Gladstone
Development Candidate, Proof of Concept
Type 1 diabetes iPS Cell Biologic UCLA
Development Candidate, Proof of Concept
Epidermolysis Bullosa iPS Cell Gene-modified, personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
Liver Disease iPS Cell Gene-modified, donor cell therapy CHLA
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy Sanford-Burnham
Development Candidate, Proof of Concept
COVID-19 iPS Cell Model system development UC Berkeley
Proof of Concept
Heart failure iPS Cell Exosomes based therapy Stanford
Development Candidate, Proof of Concept
Angelman Syndrome,
Autism
iPS Cell Gene Therapy, cell free UC Davis
Development Candidate, Proof of Concept
Skeletal/Smooth Muscle disorders Embryonic Stem Cell,
iPS Cell
Exosomes based therapy Stanford
Development Candidate, Proof of Concept
Intestinal Disease,
Neurological Disorders
iPS Cell Donor cell therapy CHLA
Pre-IND/IDE or Equivalent
Epidermolysis Bullosa iPS Cell Gene-modified, personalized cell therapy Stanford
Development Candidate, Proof of Concept
Canavan Disease iPS Cell Gene-modified, personalized cell therapy COH
Pre-IND/IDE or Equivalent
Ovarian Cancer iPS Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
Heart Disease iPS Cell Model system development Organos Inc.
Tool/Resources/Bottleneck
Heart Disease iPS Cell Model system development Stanford
Development Candidate, Proof of Concept
Neurological Disorders iPS Cell Gene Therapy, cell free Navega Therapeutics
Development Candidate, Proof of Concept
Spinal Cord Injury iPS Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Bladder or Urinary Tract Disorder,
Incontinence
iPS Cell Personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy UCLA
Development Candidate, Proof of Concept
Stroke iPS Cell Donor cell therapy UCLA
Pre-IND/IDE or Equivalent
Neurological Disorders,
Sanfilippo Syndrome/MPS III
iPS Cell Gene-modified, personalized cell therapy UC Irvine
Development Candidate, Proof of Concept
Traumatic Brain Injury iPS Cell Donor cell therapy UC Irvine
Development Candidate, Research Insights
Heart Disease iPS Cell Donor cell therapy UC Davis
Development Candidate, Proof of Concept
Huntington's Disease iPS Cell Gene Therapy, cell free UCSD
Development Candidate, Proof of Concept
COVID-19 iPS Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Retinitis Pigmentosa Other Donor cell therapy jCyte
Clinical Trial, Phase 2
Brain Cancer Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Metabolic Disorders Somatic Cell Gene-modified, personalized cell therapy Immusoft Corporation
Pre-IND/IDE or Equivalent
Duchenne Muscular Dystrophy Somatic Cell Gene Therapy, cell free MyoGene Bio LLC
Pre-IND/IDE or Equivalent
B cell cancers Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Brain Cancer Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Multiple Myeloma Somatic Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Kidney Disease Somatic Cell Gene Therapy, cell free UCSF
Development Candidate, Proof of Concept
Retinitis Pigmentosa Somatic Cell Gene Therapy, cell free Ray Therapeutics, INC
Pre-IND/IDE or Equivalent
IPEX Syndrome,
Immune Disease
Vital Research Opportunity Gene Therapy, cell free Stanford
IND
Parkinson's Disease Vital Research Opportunity Gene Therapy, cell free Brain Neurotherapy Bio
Clinical Trial, Phase 1 or Phase 1/2
COVID-19,
Respiratory Disorders
Other,
Vital Research Opportunity
Convalescent Plasma COH
Research Insights

Pages

Icon for csv export